Sign in

CIK 0000034956

  • Non-accelerated filer
  • Smaller reporting company

TENAX THERAPEUTICS, INC.

Sign in to watch
Ticker
TENX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
262593535
Phone
+1 919-855-2100
Business address
101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
Former names
OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
  1. 4 Open-market buy 10% owner bought 34,903 shares at an average $1.51 ($52,700)
  2. 4 Open-market buy Director bought 311,481 shares at an average $1.48 ($460,443)
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market buy Director bought 5,000 shares at $0.95 ($4,774)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Returned to the company CFO returned 5,720 shares (to the company)
  18. 4 Returned to the company CFO returned 6,425 shares (to the company)
  19. 4 Returned to the company CFO returned 98 shares (to the company)
  20. 4 Open-market buy Director bought 12,950 shares at an average $0.45 ($5,887)

Page 5 of 11 · 206 filings